Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.

doi:10.1007/s00280-024-04666-4

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.

Cancer chemotherapy and pharmacology - 1 Aug 2024

Uryu Kiyoaki, Imamura Yoshinori, Shimoyama Rai, Mase Takahiro, Fujimura Yoshiaki, Hayashi Maki, Ohtaki Megu, Otani Keiko, Hibino Makoto, Horiuchi Shigeto, Fukui Tomoya, Fukai Ryuta, Chihara Yusuke, Iwase Akihiko, Yamada Noriko, Tamura Yukihiro, Harada Hiromasa, Shinozaki Nobuaki, Shimada Toyoshi, Tsuya Asuka, Fukuoka Masahiro, Minami Hironobu

Abstract excerpt

PURPOSE: This study aimed to examine the prognostic impact of concomitant pH-regulating drug use in patients with epidermal growth factor receptor (EGFR)-mutation-positive non-small-cell lung cancer (NSCLC) receiving EGFR-tyrosine kinase inhibitors (TKIs). METHODS: We conducted a nationwide retrospective cohort study and reviewed clinical data of consecutive patients with NSCLC treated with the first-line...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to ErbB Receptors

Share to Hydrogen-Ion Concentration

Share to Lung Neoplasms

Share to Protein Kinase Inhibitors

Share to Proton Pump Inhibitors

Share to Survival Rate

Share to Tyrosine Kinase Inhibitors

Source

Open in PubMed

Identifiers

PMID: 38584202
DOI: 10.1007/s00280-024-04666-4

Genes

EGFR

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Prognostic impact of concomitant pH-regulating drugs in patients with non-small cell lung cancer receiving epidermal growth factor receptor tyrosine kinase inhibitors: the Tokushukai REAl-world Data project 01-S1.PMID 38584202Read ↗

Clinical impact of tetracyclines and/or proton pump inhibitors on the efficacy of epidermal growth factor receptor inhibitors in non-small cell lung cancer: a retrospective cohort study.Semantic proximity Read ↗

[A review: drug-drug interactions of epithelial growth factor receptor-tyrosine kinase inhibitors].Semantic proximity Read ↗

Assessment of anticancer drug utilization pattern and patients’ survival—A single center experience from Saudi ArabiaSemantic proximity Read ↗

EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction.Semantic proximity Read ↗

Efficacy and safety of time-of-day infusion of pemetrexed plus platinum for patients with advanced non-small cell lung cancer: A retrospective studySemantic proximity Read ↗

Clinical Impact of Gastric Acid-Suppressing Medication Use on the Efficacy of Erlotinib and Gefitinib in Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations.Semantic proximity Read ↗

Influence of palliative care on medication: results of a retrospective analysis of 10,464 outpatients in GermanySemantic proximity Read ↗

Effects of H2-Receptor Antagonists on the Exposure of DacomitinibSemantic proximity Read ↗

Anticancer Drug Utilization and Prescription Practices in a Saudi Cancer Center (2014-2022)Semantic proximity Read ↗

Effects of Concomitant Medication Use on Gefitinib-Induced Hepatotoxicity.Semantic proximity Read ↗

Associations between proton pump inhibitors and Alzheimer’s disease: A nested case-control study using a Korean nationwide health screening cohortSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.